The Globe and Mail reports in its Friday edition that Desjardins's Doug Young is keeping his "buy" call and $94 share target on Sun Life Financial intact. The Globe's David Leeder writes that analysts on average target the shares at $91.30. Mr. Young says in a note: "There are several themes we like, including: (1) a peer-leading medium-term underlying ROE target of 20 per cent; (2) several potential earnings growth drivers over the coming year(s) -- improved U.S. dental results, potentially more stable U.S. stop-loss results, momentum in Asia, SLC Management hitting its stride and stock buybacks; (3) $6-billion in excess capital and debt capacity (excludes capital earmarked for SLC buy ups in 2026), and it generates an attractive amount of excess capital annually; and (4) valuation -- we believe concerns with U.S. dental, U.S. stop-loss and MFS are more than factored into Sun Life's current valuation." The Globe reported on Oct. 11, 2024, Feb. 14, 2025, and April 22, 2025, that Mr. Young had reaffirmed his "buy" recommendation for Sun Life when it could be had for $78.76, $78.20 and $79.03. The Globe reported on Nov. 11, 2025, that RBC had cut Sun Life to "sector perform" from "outperform," when it was worth $81.37.